Glucose control in diabetes during home confinement for the first pandemic wave of COVID-19: a meta-analysis of observational studies.


Journal

Acta diabetologica
ISSN: 1432-5233
Titre abrégé: Acta Diabetol
Pays: Germany
ID NLM: 9200299

Informations de publication

Date de publication:
Dec 2021
Historique:
received: 04 04 2021
accepted: 29 05 2021
pubmed: 24 6 2021
medline: 26 11 2021
entrez: 23 6 2021
Statut: ppublish

Résumé

To assess the effect on glycaemic control of confinement due to lockdown measures, during COVID-19 pandemic, in people with type 1 (T1DM) and type 2 (T2DM) diabetes. Meta-analysis of observational studies reporting measures of glucose control and variability before and during and/or after periods of confinement caused by COVID-19 in 2020 and/or 2021. We included 27 studies on T1DM. No significant change in Hba1c was observed after lockdown (WMD - 1.474 [- 3.26; 0.31] mmol/mol, I Lockdown showed no significant detrimental effect on HbA1c in either T1DM or T2DM. Conversely, home confinement led to a reduction in mean glucose and glucose variability in T1DM, although with a high heterogeneity of results.

Identifiants

pubmed: 34159476
doi: 10.1007/s00592-021-01754-2
pii: 10.1007/s00592-021-01754-2
pmc: PMC8219181
doi:

Substances chimiques

Blood Glucose 0

Types de publication

Journal Article Meta-Analysis

Langues

eng

Sous-ensembles de citation

IM

Pagination

1603-1611

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2021. The Author(s).

Références

Acta Diabetol. 2021 Feb;58(2):231-237
pubmed: 33067723
Diabetes Res Clin Pract. 2020 Nov;169:108440
pubmed: 32926958
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):1963-1966
pubmed: 33059299
Saudi Med J. 2021 Jan;42(1):44-48
pubmed: 33399170
Front Endocrinol (Lausanne). 2020 Dec 07;11:595735
pubmed: 33424771
Diabetes Care. 2021 Jan;44(1):e18-e21
pubmed: 33127611
Diabetes Metab Syndr. 2021 Jan-Feb;15(1):93-98
pubmed: 33316765
Diabetes Res Clin Pract. 2020 Oct;168:108379
pubmed: 32853692
Diabet Med. 2021 Jan;38(1):e14433
pubmed: 33073388
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):1815-1819
pubmed: 32956926
Acta Diabetol. 2020 Dec;57(12):1511-1517
pubmed: 33026497
Diabetes Res Clin Pract. 2020 Aug;166:108297
pubmed: 32623042
Diabetes Res Clin Pract. 2021 Mar;173:108697
pubmed: 33571600
Front Endocrinol (Lausanne). 2020 Oct 28;11:584642
pubmed: 33250859
Diabetes Metab Syndr. 2020 Sep - Oct;14(5):1213-1216
pubmed: 32679527
Diabetes Care. 2020 Aug;43(8):e88-e89
pubmed: 32540921
Diabetes Technol Ther. 2020 Jul;22(7):527-534
pubmed: 32522031
BMJ Open Diabetes Res Care. 2020 Oct;8(2):
pubmed: 33115820
Diabetes Res Clin Pract. 2020 Aug;166:108307
pubmed: 32650036
Diabetes Metab Res Rev. 2021 Feb;37(2):e3378
pubmed: 32592519
Int J Diabetes Dev Ctries. 2020 Sep 15;:1-5
pubmed: 32952333
Diabetes Metab Syndr. 2020 Sep - Oct;14(5):833-838
pubmed: 32540738
Diabetes Res Clin Pract. 2020 Aug;166:108298
pubmed: 32623031
Diabetes Res Clin Pract. 2020 Sep;167:108354
pubmed: 32739380
Pol Arch Intern Med. 2020 May 29;130(5):452-454
pubmed: 32385978
Diabetes Res Clin Pract. 2020 Dec;170:108514
pubmed: 33068663
Endocr J. 2021 Feb 28;68(2):201-210
pubmed: 32999133
Acta Diabetol. 2021 Mar;58(3):383-388
pubmed: 33125525
J Diabetes. 2020 Dec;12(12):946-948
pubmed: 32909344
Diabetes Care. 2020 Aug;43(8):e86-e87
pubmed: 32503838
Diabetes Technol Ther. 2021 May;23(5):399-400
pubmed: 33237817
Diabet Med. 2021 Jan;38(1):e14414
pubmed: 33030220
Popul Health Manag. 2021 Feb;24(1):8-9
pubmed: 32603249
J Telemed Telecare. 2021 Feb 1;:1357633X20985763
pubmed: 33525952
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):1579-1584
pubmed: 32858476
Nutrients. 2020 Sep 30;12(10):
pubmed: 33008059
Diabetes Ther. 2020 Jun;11(6):1369-1379
pubmed: 32395187
Acta Diabetol. 2021 May;58(5):661-664
pubmed: 33532867
Diabetes Res Clin Pract. 2020 Aug;166:108348
pubmed: 32711000
Diabetes Res Clin Pract. 2020 Dec;170:108468
pubmed: 32987040
Endocrine. 2020 Feb;67(2):354-362
pubmed: 31927750
Acta Diabetol. 2021 Jun;58(6):697-705
pubmed: 33511493
Can Fam Physician. 2020 Oct;66(10):745-747
pubmed: 33077454
Diabetes Technol Ther. 2021 Apr;23(4):320-321
pubmed: 33232615
Diabetes Res Clin Pract. 2020 Aug;166:108302
pubmed: 32623034
Diabetes Res Clin Pract. 2020 Dec;170:108513
pubmed: 33075424
Diabet Med. 2021 Jan;38(1):e14374
pubmed: 32740984
Diabetes Technol Ther. 2020 Jun;22(6):444-448
pubmed: 32396395
Prim Care Diabetes. 2021 Jun;15(3):424-427
pubmed: 33441263
Acta Diabetol. 2021 Apr;58(4):431-436
pubmed: 33219884
Diabetes Metab Res Rev. 2021 Sep;37(6):e3404
pubmed: 32918324
Nutr Diabetes. 2021 Jan 5;11(1):1
pubmed: 33414391
Arch Endocrinol Metab. 2021 Nov 1;65(1):105-111
pubmed: 33166438
Diabetes Metab J. 2021 Jan;45(1):109-114
pubmed: 33264833
J Pediatr Endocrinol Metab. 2020 Nov 13;34(2):217-223
pubmed: 33185578
J Diabetes Complications. 2020 Dec;34(12):107748
pubmed: 33059981
Lancet. 2020 May 30;395(10238):1678-1680
pubmed: 32401713
J Endocr Soc. 2020 Oct 13;4(12):bvaa149
pubmed: 33173841
Diabetes Res Clin Pract. 2020 Oct;168:108393
pubmed: 32858098

Auteurs

Giovanni Antonio Silverii (GA)

Diabetes Unit, Experimental and Clinical Biomedical Sciences "Mario Serio" Department, AOU Careggi Hospital, University of Florence, Largo Brambilla 3, 50134, Florence, Italy. antonio.silverii@gmail.com.

Chiara Delli Poggi (C)

Diabetes Unit, Experimental and Clinical Biomedical Sciences "Mario Serio" Department, AOU Careggi Hospital, University of Florence, Largo Brambilla 3, 50134, Florence, Italy.

Ilaria Dicembrini (I)

Diabetes Unit, Experimental and Clinical Biomedical Sciences "Mario Serio" Department, AOU Careggi Hospital, University of Florence, Largo Brambilla 3, 50134, Florence, Italy.

Matteo Monami (M)

Diabetes Unit, Experimental and Clinical Biomedical Sciences "Mario Serio" Department, AOU Careggi Hospital, University of Florence, Largo Brambilla 3, 50134, Florence, Italy.

Edoardo Mannucci (E)

Diabetes Unit, Experimental and Clinical Biomedical Sciences "Mario Serio" Department, AOU Careggi Hospital, University of Florence, Largo Brambilla 3, 50134, Florence, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH